| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $10.8M | — | +3.1% |
| SG&A Expense | $7.4M | — | +40.5% |
| Operating Income | -$17.8M | — | -22.2% |
| Income Tax | $0 | — | — |
| Net Income | -$16.4M | — | -19.8% |
| EPS (Basic) | -$0.10 | — | +33.3% |
| EPS (Diluted) | -$0.10 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $120.8M | +205.5% | +512.0% |
| Current Assets | $172.2M | -4.4% | +82.8% |
| Total Assets | $173.3M | -4.3% | +83.8% |
| Current Liabilities | $5.7M | -31.2% | -33.2% |
| Total Liabilities | $5.7M | -31.2% | -33.2% |
| Stockholders' Equity | $167.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.1M | — | -193.9% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$80.5M | — | -482.3% |
| Financing Cash Flow | $2.9M | — | — |
| Free Cash Flow | -$12.1M | — | -192.9% |
| +95.5% |